FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology, and can be used to predict metastases of breast cancer in the bones. Method includes a laboratory biochemical study, in which the concentration of fibrinogen in plasma is determined in patients with breast cancer. When the initial level of fibrinogen is within 6.9±0.6 g/l predict an unfavorable course of the disease and the presence of bone metastases in the absence of clinical symptoms of progression.
EFFECT: use of the invention makes it possible to determine the generalization of the tumor process in the absence of clinical signs of disease manifestation and timely adjust the treatment plan for patients based on the obtained values of fibrinogen concentration.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF PATIENT WITH OSTEOLYTIC METASTASIS | 1999 |
|
RU2153358C1 |
| METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
| METHOD FOR TREATMENT OF PLURAL OSTEAL METASTASISES DURING MAMMARY GLAND CANCER | 2007 |
|
RU2332992C1 |
| METHOD FOR EVALUATING THE BONE SCINTIGRAPHY RESULTS IN PATIENTS WITH METASTATIC LESIONS OF THE SKELETON BONES | 2022 |
|
RU2791402C1 |
| METHOD FOR DETERMINING PATHOLOGICAL PROCESS GENERALIZATION IN THE CASES OF ONCOLOGICAL DISEASES | 2002 |
|
RU2241987C2 |
| METHOD OF PREDICTION OF POSTOPERATIVE COMPLICATIONS OF PATIENT UNDERWENT SURGICAL TREATMENT OF BREAST CANCER | 2017 |
|
RU2683692C1 |
| METHOD FOR PREDICTING RELAPSE OF MAMMARY CANCER | 2003 |
|
RU2263319C2 |
| METHOD OF GENERALIZING THE PROCESS PROGNOSIS FOR EWING'S SARCOMA IN CHILDREN | 2020 |
|
RU2740527C1 |
| RECURRENT AND METASTASING CERVICAL CARCINOMA TREATMENT EFFECTIVENESS PREDICTION METHOD | 2007 |
|
RU2353928C1 |
| COMBINATION CELL IMMUNOTHERAPY OF MALIGNANT TUMORS | 2020 |
|
RU2787623C2 |
